TrialNature medicine2022

Empagliflozin add-on therapy to closed-loop insulin delivery in type 1 diabetes: a 2 × 2 factorial randomized crossover trial.

Ahmad Haidar et al.PubMed ↗Publisher ↗

No numbers read from the abstract.